1. Home
  2. ICUI vs FSM Comparison

ICUI vs FSM Comparison

Compare ICUI & FSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • FSM
  • Stock Information
  • Founded
  • ICUI 1984
  • FSM 1990
  • Country
  • ICUI United States
  • FSM Canada
  • Employees
  • ICUI N/A
  • FSM N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • FSM Precious Metals
  • Sector
  • ICUI Health Care
  • FSM Basic Materials
  • Exchange
  • ICUI Nasdaq
  • FSM Nasdaq
  • Market Cap
  • ICUI 3.0B
  • FSM 2.8B
  • IPO Year
  • ICUI 1992
  • FSM N/A
  • Fundamental
  • Price
  • ICUI $123.69
  • FSM $8.07
  • Analyst Decision
  • ICUI Buy
  • FSM Hold
  • Analyst Count
  • ICUI 6
  • FSM 1
  • Target Price
  • ICUI $179.40
  • FSM $10.50
  • AVG Volume (30 Days)
  • ICUI 214.7K
  • FSM 19.3M
  • Earning Date
  • ICUI 11-06-2025
  • FSM 11-05-2025
  • Dividend Yield
  • ICUI N/A
  • FSM N/A
  • EPS Growth
  • ICUI N/A
  • FSM 7355.92
  • EPS
  • ICUI N/A
  • FSM 0.50
  • Revenue
  • ICUI $2,372,504,000.00
  • FSM $1,187,211,000.00
  • Revenue This Year
  • ICUI N/A
  • FSM N/A
  • Revenue Next Year
  • ICUI N/A
  • FSM N/A
  • P/E Ratio
  • ICUI N/A
  • FSM $15.88
  • Revenue Growth
  • ICUI 2.96
  • FSM 46.81
  • 52 Week Low
  • ICUI $107.00
  • FSM $4.13
  • 52 Week High
  • ICUI $196.26
  • FSM $9.82
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 55.19
  • FSM 42.66
  • Support Level
  • ICUI $119.74
  • FSM $7.69
  • Resistance Level
  • ICUI $124.17
  • FSM $8.34
  • Average True Range (ATR)
  • ICUI 3.35
  • FSM 0.44
  • MACD
  • ICUI 1.00
  • FSM -0.18
  • Stochastic Oscillator
  • ICUI 95.89
  • FSM 17.88

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About FSM Fortuna Silver Mines Inc (Canada)

Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.

Share on Social Networks: